Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.
作者信息
Walkey Allan J, Bor Jacob
机构信息
1 Boston University School of Medicine Boston, Massachusetts.
2 Boston University School of Public Health Boston, Massachusetts.
出版信息
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1399. doi: 10.1164/rccm.201508-1533LE.
Abstract
摘要
相似文献
1
Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.试验中基于风险的治疗效果异质性以及使用回归间断设计监测临床疗效的意义。
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1399. doi: 10.1164/rccm.201508-1533LE.
2
Reply: Risk-based Heterogeneity of Treatment Effect in Trials and Implications for Surveillance of Clinical Effectiveness Using Regression Discontinuity Designs.回复：试验中基于风险的治疗效果异质性及其对使用回归间断设计监测临床疗效的意义。
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1399-400. doi: 10.1164/rccm.201508-1625LE.
3
Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.治疗效果异质性对重症监护随机试验报告与分析的影响
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51. doi: 10.1164/rccm.201411-2125CP.
4
Increasing power in randomized controlled trials.增加随机对照试验的效能
Crit Care Med. 2009 Oct;37(10):2840-1. doi: 10.1097/CCM.0b013e3181ad7b62.
5
Ethnic and Sex Representation in Trials Shaping Best Practice for COVID-19.试验中的种族和性别代表性塑造了COVID-19的最佳实践。
Ann Am Thorac Soc. 2021 Feb;18(2):371-372. doi: 10.1513/AnnalsATS.202006-622RL.
6
Evidence Supporting Clinical Use of Proportional Assist Ventilation: A Systematic Review and Meta-Analysis of Clinical Trials.支持比例辅助通气临床应用的证据：临床试验的系统评价和荟萃分析。
J Intensive Care Med. 2020 Jul;35(7):627-635. doi: 10.1177/0885066618769021. Epub 2018 May 3.
7
Noninvasive ventilation routine therapy for community-acquired pneumonia? Not so fast!无创通气用于社区获得性肺炎的常规治疗？没那么快！
Intensive Care Med. 2001 May;27(5):797-9. doi: 10.1007/s001340100919.
8
Should blood transfusion be individualised? We are not sure.输血应该个体化吗？我们不确定。
Intensive Care Med. 2015 Nov;41(11):1980-2. doi: 10.1007/s00134-015-4034-4. Epub 2015 Sep 10.
9
Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study.重症监护医学中随机对照试验的患者入选标准：一项国际多中心观察性研究。
Crit Care Med. 2017 Feb;45(2):216-224. doi: 10.1097/CCM.0000000000002061.
10
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?随机对照试验中的基线特征与统计效能：选择、预后靶向还是协变量调整？
Crit Care Med. 2009 Oct;37(10):2683-90. doi: 10.1097/ccm.0b013e3181ab85ec.
引用本文的文献
1
Regression discontinuity designs in healthcare research.医疗保健研究中的回归断点设计。
BMJ. 2016 Mar 14;352:i1216. doi: 10.1136/bmj.i1216.
本文引用的文献
1
Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.治疗效果异质性对重症监护随机试验报告与分析的影响
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51. doi: 10.1164/rccm.201411-2125CP.
2
Three approaches to causal inference in regression discontinuity designs.回归断点设计中因果推断的三种方法。
Epidemiology. 2015 Mar;26(2):e28-30; discussion e30. doi: 10.1097/EDE.0000000000000256.
3
Regression discontinuity designs are underutilized in medicine, epidemiology, and public health: a review of current and best practice.回归不连续性设计在医学、流行病学和公共卫生领域未得到充分利用：对当前和最佳实践的综述。
J Clin Epidemiol. 2015 Feb;68(2):122-33. doi: 10.1016/j.jclinepi.2014.06.021.
4
Regression discontinuity designs in epidemiology: causal inference without randomized trials.流行病学中的回归断点设计：无需随机试验的因果推断
Epidemiology. 2014 Sep;25(5):729-37. doi: 10.1097/EDE.0000000000000138.
Zotero 插件